BRIEF-Regeneron announces settlement of patent litigation with Genentech – CNBC

January 3, 2012 Posted By: Leave a comment
Jan 3 (Reuters) - Regeneron Pharmaceuticals Inc: * Announces settlement of patent litigation with genentech for U.S. ophthalmic sales of eylea* (aflibercept) injection * Says will make payments to genentech based on u.s. sales of eylea through may 7, 2016 ...
Subscribe to LegalLaw247.Com Newsletter

Leave a Reply

Your email address will not be published. Required fields are marked *

*

CAPTCHA Image

*

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>